… TL Tammela has received consultancy honoraria from Astellas, Bayer, Janssen-Cilag,
and Lidds Ab. A. Salonen has taken part in congress with support from Astellas Pharma, …

Purpose: The biodegradable PLGA (a copolymer of L-lactide and glycolide) urethral stent
with a spiral configuration has been used clinically for the prevention of postoperative urinary …

Background The European Randomised study of Screening for Prostate Cancer (ERSPC)
has shown significant reductions in prostate cancer mortality after 9 years and 11 years of …

Background The European Randomized Study of Screening for Prostate Cancer was
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen (PSA) …

Background Darolutamide is a potent androgen-receptor inhibitor that has been associated
with increased overall survival among patients with nonmetastatic, castration-resistant …

Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …

Background Bone metastases are a major cause of morbidity and mortality in men with
prostate cancer. Preclinical studies suggest that osteoclast inhibition might prevent bone …

Background We conducted a study to determine whether dutasteride reduces the risk of
incident prostate cancer, as detected on biopsy, among men who are at increased risk for the …

Background Androgen-deprivation therapy is well-established for treating prostate cancer
but is associated with bone loss and an increased risk of fracture. We investigated the effects …

The expression level of the androgen receptor (AR) gene in androgen-dependent and -independent
prostate cancer was determined by using real-time quantitative reverse transcription…